With rules about pregnancy medications constantly changing, it can feel overwhelming to know what to do when you’re feeling sick.
It usually comes down to weighing the benefits for a mother with a health condition — even one as simple as a headache — against potential risks to her developing baby.
The problem: Scientists can’t ethically perform drug testing on a pregnant woman. It’s not accurate to say a medication is 100 percent safe for a pregnant woman (simply because it’s never been studied or tested).
In the past, medications were assigned to
In 2015, the Food and Drug Administration (FDA) started to implement a new labeling system for drugs.
Below is a sampling of a few of the drugs that we know pregnant women should avoid.
Did you know? Antibiotics are often linked to adverse reactions in pregnant women.
Ciprofloxacin (Cipro) and levofloxacin are also types of antibiotics. These drugs could cause problems with the baby’s muscle and skeletal growth as well as joint pain and potential nerve damage in the mother.
Ciprofloxacin and levofloxacin are both fluoroquinolone antibiotics.
Sulfonamides are a group of antibiotic medications. They’re also known as sulfa drugs.
High doses of this OTC pain reliever can cause many serious problems, including:
- delayed onset of labor
- premature closing of the fetal ductus arteriosus, an important artery
- hemorrhaging for both mother and baby
- necrotizing enterocolitis, or damage to the lining of the intestines
- oligohydramnios, or low levels of amniotic fluid
- fetal kernicterus, a type of brain damage
- abnormal vitamin K levels
Most experts agree that ibuprofen is probably safe to use in small to moderate doses in early pregnancy.
Drug labels listing pregnancy letter categories will be completely phased out
One important note about the new labeling system is that it doesn’t affect over-the-counter (OTC) medications at all. It’s only used for prescription drugs.
The first subsection of the new label is titled “Pregnancy.”
This subsection includes relevant data about the drug, information on risks, and information on how the drug may affect labor or delivery. If a
Pregnancy exposure registries are studies that collect information about different medications and their possible effects on pregnant women, breastfeeding women, and their babies. These registries aren’t conducted by the FDA.
Women who are interested in participating in a pregnancy exposure registry can volunteer, but participation isn’t required.
The second subsection of the new label is titled “Lactation.”
This part of the label includes information for women who are breastfeeding. Information such as the amount of the drug that will be present in breast milk and the drug’s potential effects on a breastfeeding infant is provided in this section. Relevant data is also included.
Females and males of reproductive potential
The third subsection of the new label is titled “Females and males of reproductive potential.”
This section includes information on whether women using the drug should undergo pregnancy testing or use specific methods of contraception. It also includes information about the drug’s effect on fertility.
If you’re not sure whether or not a medication is safe to take during pregnancy, ask your doctor. Also, ask about updated studies, as pregnancy drug labels can change with new research.
Chaunie Brusie, BSN, is a registered nurse in labor and delivery, critical care, and long-term care nursing. She lives in Michigan with her husband and four young children and is the author of “Tiny Blue Lines.”